Hims & Hers Health, Inc. (HIMS)
After hours:
| Previous close | 23.25 |
| Open | 23.72 |
| Bid | 21.67 x 800 |
| Ask | 21.69 x 1100 |
| Day's range | 21.36 - 24.23 |
| 52-week range | 5.65 - 25.74 |
| Volume | |
| Avg. volume | 11,258,503 |
| Market cap | 4.676B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
SAN FRANCISCO, July 22, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Kåre Schultz to the company’s Board of Directors.
- Business Wire
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
SAN FRANCISCO, July 15, 2024--Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
- Business Wire
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
SAN FRANCISCO, May 20, 2024--Hims & Hers Health, Inc., the leading health and wellness platform, today announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving customers an affordable way to consistently access safe, high-quality weight loss treatment.
